{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:50:25Z","timestamp":1772211025099,"version":"3.50.1"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["Grant numbers: UID\/Multi\/04413\/2013 and UID\/Multi\/04413\/2020"],"award-info":[{"award-number":["Grant numbers: UID\/Multi\/04413\/2013 and UID\/Multi\/04413\/2020"]}]},{"DOI":"10.13039\/501100007440","name":"Hans B\u00f6ckler Stiftung","doi-asserted-by":"publisher","award":["PhD Scholarship ID: 385759"],"award-info":[{"award-number":["PhD Scholarship ID: 385759"]}],"id":[{"id":"10.13039\/501100007440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cotrimoxazole and isoniazid preventive therapy (CPT, IPT) have been shown to be efficacious therapies for the prevention of opportunistic infections and tuberculosis (TB) among people living with human immunodeficiency virus (HIV). Despite governments\u2019 efforts to translate World Health Organization recommendations into practice, implementation remains challenging. This review aimed to explore and compare CPT and IPT with respect to similarities and differences of barriers identified across high TB\/HIV burden countries. A secondary objective was to identify facilitators for implementing both preventive therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched MEDLINE, Web of Science and SCOPUS databases for peer-reviewed literature published before September 2020. We extracted and synthesized our findings using Maxqda software. We applied framework synthesis in conjunction with metasummary to compare both therapies with respect to similarities and differences of barriers identified across seven health system components (in line with the modified WHO\u2019s Framework for action). Protocol registration: PROSPERO (CRD42019137778).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>We identified four hundred and eighty-two papers, of which we included forty for review. Although most barrier themes were identical for both preventive therapies, we identified seven intervention-specific themes. Like for CPT, barriers identified for IPT were most frequently classified as \u2018service delivery-related barriers\u2019 and \u2018patient &amp; community-related barriers\u2019. \u2018Health provider-related barriers\u2019 played an important role for implementing IPT. Most facilitators identified referred to health system strengthening activities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For researchers with limited working experience in high TB\/HIV burden countries, this review can provide valuable insights about barriers that may arise at different levels of the health system. For policymakers in high TB\/HIV burden countries, this review offers strategies for improving the delivery of IPT (or any newer therapy regimen) for the prevention of TB. Based on our findings, we suggest initial and continuous stakeholder involvement, focusing on the efficient use and reinforcement of existing resources for health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0251612","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T13:26:28Z","timestamp":1646141188000},"page":"e0251612","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid\u2014Preventive therapies for people living with HIV"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0231-5017","authenticated-orcid":true,"given":"Pia","family":"M\u00fcller","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0506-1294","authenticated-orcid":true,"given":"Lu\u00eds","family":"Velez Lap\u00e3o","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"pone.0251612.ref001","unstructured":"UNAIDS. Global HIV & AIDS statistics\u2014Fact sheet. 2021. https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"pone.0251612.ref002","unstructured":"World Health Organization. Tuberculosis. Key facts 2021. 14 October 2021:[https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis."},{"key":"pone.0251612.ref003","unstructured":"World Health Organization. Global Tuberculosis Report 2020. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013131."},{"key":"pone.0251612.ref004","volume-title":"chapter 5: Clinical guidelines: Managing common coinfections and comorbidities","author":"World Health Organization","year":"2016"},{"key":"pone.0251612.ref005","doi-asserted-by":"crossref","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1. Prevention: Tuberculosis preventive treatment 2020. https:\/\/www.who.int\/publications\/i\/item\/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment.","DOI":"10.30978\/TB2021-2-86"},{"issue":"4","key":"pone.0251612.ref006","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2352-3018(15)00005-3","article-title":"Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis","volume":"2","author":"AB Suthar","year":"2015","journal-title":"The Lancet HIV"},{"issue":"1","key":"pone.0251612.ref007","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12879-019-4031-2","article-title":"The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis","volume":"19","author":"D Geremew","year":"2019","journal-title":"BMC infectious diseases"},{"issue":"9","key":"pone.0251612.ref008","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/tmi.12919","article-title":"Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study","volume":"22","author":"SP Eholi\u00e9","year":"2017","journal-title":"Tropical Medicine and International Health"},{"issue":"11","key":"pone.0251612.ref009","doi-asserted-by":"crossref","first-page":"e1080","DOI":"10.1016\/S2214-109X(17)30372-8","article-title":"Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial","volume":"5","author":"A Badje","year":"2017","journal-title":"The Lancet Global Health"},{"issue":"1","key":"pone.0251612.ref010","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"C Akolo","year":"2010","journal-title":"Cochrane database of systematic reviews"},{"issue":"1","key":"pone.0251612.ref011","first-page":"30","article-title":"Provisional WHO\/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV\/AIDS in Africa","volume":"1","author":"World Health Organization","year":"2000","journal-title":"African Health Sciences"},{"key":"pone.0251612.ref012","unstructured":"WHO\/ UNAIDS. Policy statement on preventive therapy against tuberculosis in people living with HIV 1998. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/64509\/WHO_TB_98.255.pdf?sequence=1."},{"issue":"4","key":"pone.0251612.ref013","doi-asserted-by":"crossref","first-page":"299","DOI":"10.5114\/hivar.2018.80263","article-title":"Health system challenges affecting the implementation of isoniazid preventive therapy in people living with HIV in Lesotho","volume":"17","author":"E Mugomeri","year":"2018","journal-title":"HIV and AIDS Review"},{"key":"pone.0251612.ref014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/DHPS.S89115","article-title":"Challenges facing effective implementation of cotrimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities","volume":"7","author":"AAR Kamuhabwa","year":"2015","journal-title":"Drug, healthcare and patient safety"},{"issue":"1","key":"pone.0251612.ref015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12630-008-9007-4","article-title":"Posing the research question: not so simple","volume":"56","author":"L Thabane","year":"2009","journal-title":"Canadian journal of anaesthesia"},{"issue":"3","key":"pone.0251612.ref016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/wvn.12134","article-title":"A guide to writing a qualitative systematic review protocol to enhance evidence-based practice in nursing and health care","volume":"13","author":"A Butler","year":"2016","journal-title":"Worldviews on Evidence-Based Nursing"},{"key":"pone.0251612.ref017","unstructured":"Joanna Briggs Institute. JBI Reviewer\u2019s Manual. Chapter 8: Mixed methods systematic reviews. Section 8.5.1 Mixed methods systematic review using a convergent integrated approach to synthesis and integration. 2017 [cited 1]. https:\/\/wiki.jbi.global\/display\/MANUAL\/8.5.1+++Mixed+methods+systematic+review+using+a+CONVERGENT+INTEGRATED+approach+to+synthesis+and+integration."},{"issue":"4","key":"pone.0251612.ref018","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"D Moher","year":"2009","journal-title":"Annals of internal medicine"},{"key":"pone.0251612.ref019","unstructured":"Cumpston M, Chandler J. Chapter IV: updating a review 2019. https:\/\/training.cochrane.org\/handbook\/current\/chapter-iv."},{"key":"pone.0251612.ref020","unstructured":"Hong QN, Pluye P, F\u00e0bregues S, Bartlett G, Boardman F, Cargo M, et al. Mixed methods appraisal tool (MMAT), version 2018. User guide. 2018. http:\/\/mixedmethodsappraisaltoolpublic.pbworks.com\/w\/file\/fetch\/127916259\/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf."},{"key":"pone.0251612.ref021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jclinepi.2017.06.020","article-title":"Cochrane Qualitative and Implementation Methods Group guidance series\u2014paper 3: methods for assessing methodological limitations, data extraction and synthesis, and confidence in synthesized qualitative findings","volume":"97","author":"J Noyes","year":"2018","journal-title":"Journal of clinical epidemiology"},{"key":"pone.0251612.ref022","unstructured":"Hannes K. Chapter 4: Critical appraisal of qualitative research: Cochrane Collaboration Qualitative Methods Group, 2011; 2011. http:\/\/cqrmg.cochrane.org\/supplemental-handbook-guidance."},{"issue":"1","key":"pone.0251612.ref023","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/nur.20176","article-title":"Using qualitative metasummary to synthesize qualitative and quantitative descriptive findings","volume":"30","author":"M Sandelowski","year":"2007","journal-title":"Research in nursing & health"},{"issue":"11","key":"pone.0251612.ref024","first-page":"1230","volume":"66","author":"M Petticrew","year":"2013","journal-title":"Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute"},{"key":"pone.0251612.ref025","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/01.aids.0000391023.03037.1f","article-title":"Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions","volume":"24","author":"H Getahun","year":"2010","journal-title":"AIDS"},{"key":"pone.0251612.ref026","unstructured":"World Health Organization. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies: World Health Organization; 2010. https:\/\/www.who.int\/healthinfo\/systems\/WHO_MBHSS_2010_full_web.pdf."},{"issue":"9","key":"pone.0251612.ref027","doi-asserted-by":"crossref","first-page":"e72712","DOI":"10.1371\/journal.pone.0072712","article-title":"Factors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals","volume":"8","author":"E Asonganyi","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"pone.0251612.ref028","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jech.2006.059394","article-title":"Publication bias in qualitative research: what becomes of qualitative research presented at conferences?","volume":"62","author":"M Petticrew","year":"2008","journal-title":"Journal of Epidemiology and Community Health"},{"issue":"1","key":"pone.0251612.ref029","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13012-017-0694-5","article-title":"Applying GRADE-CERQual to qualitative evidence synthesis findings\u2013paper 7: understanding the potential impacts of dissemination bias","volume":"13","author":"A Booth","year":"2018","journal-title":"Implementation Science"},{"issue":"1","key":"pone.0251612.ref030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4314\/ahs.v15i1.7","article-title":"Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis","volume":"15","author":"A Okwera","year":"2015","journal-title":"Afr Health Sci"},{"issue":"10","key":"pone.0251612.ref031","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1007\/s10461-015-1159-y","article-title":"Effectiveness of Peer Support on Care Engagement and Preventive Care Intervention Utilization Among Pre-antiretroviral Therapy, HIV-Infected Adults in Rakai, Uganda: A Randomized Trial","volume":"19","author":"LW Chang","year":"2015","journal-title":"AIDS and Behavior"},{"key":"pone.0251612.ref032","article-title":"The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe","volume":"14","author":"AK Chan","year":"2014","journal-title":"BMC health services research"},{"key":"pone.0251612.ref033","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12889-015-2136-0","article-title":"Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe","volume":"15","author":"EL Sibanda","year":"2015","journal-title":"BMC public health"},{"key":"pone.0251612.ref034","article-title":"Resistance of commensal intestinal Escherichia coli and other enterics to co-trimoxazole and commonly used antibiotics in HIV\/AIDS patients","author":"KD Mwambete","year":"2013","journal-title":"Clinical Microbiology: Open Access"},{"key":"pone.0251612.ref035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/DHPS.S119073","article-title":"Implementation of co-trimoxazole preventive therapy policy for malaria in HIV-infected pregnant women in the public health facilities in Tanzania","volume":"8","author":"AA Kamuhabwa","year":"2016","journal-title":"Drug, healthcare and patient safety"},{"issue":"8","key":"pone.0251612.ref036","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5588\/ijtld.11.0753","article-title":"Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care","volume":"16","author":"G Louwagie","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"pone.0251612.ref037","first-page":"955","article-title":"Health system barriers affecting the implementation of collaborative TB-HIV services in Uganda","volume":"13","author":"R Okot-Chono","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"pone.0251612.ref038","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1097\/QAI.0000000000001378","article-title":"Improved HIV and TB Knowledge and Competence among Mid-level Providers in a Cluster-Randomized Trial of One-on-One Mentorship for Task Shifting","volume":"75","author":"S Naikoba","year":"2017","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"8","key":"pone.0251612.ref039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069548","article-title":"Scaling Up Paediatric HIV Care with an Integrated, Family-Centred Approach: An Observational Case Study from Uganda","volume":"8","author":"E Luyirika","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"pone.0251612.ref040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/trstmh\/tru110","article-title":"Delivering TB\/HIV services in Ghana: a comparative study of service delivery models","volume":"108","author":"GA Ansa","year":"2014","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"9","key":"pone.0251612.ref041","first-page":"992","article-title":"Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women\u2019s health services","volume":"15","author":"C Horwood","year":"2010","journal-title":"Tropical Medicine and International Health"},{"issue":"2","key":"pone.0251612.ref042","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/jgid.jgid_138_18","article-title":"Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors","volume":"12","author":"AV Adepoju","year":"2020","journal-title":"J Glob Infect Dis"},{"issue":"3","key":"pone.0251612.ref043","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00002030-199509030-00008","article-title":"Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre","volume":"9","author":"T Aisu","year":"1995","journal-title":"AIDS"},{"issue":"8","key":"pone.0251612.ref044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103205","article-title":"A Clinical Decision Support System for Integrating Tuberculosis and HIV Care in Kenya: A Human-Centered Design Approach","volume":"9","author":"C Catalani","year":"2014","journal-title":"PLoS ONE"},{"issue":"Suppl 5","key":"pone.0251612.ref045","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1097\/01.aids.0000391022.95412.a6","article-title":"The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB\/HIV in Rio (THRio) study","volume":"24","author":"B Durovni","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"pone.0251612.ref046","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1002\/hsr2.158","article-title":"How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers","volume":"3","author":"L Faust","year":"2020","journal-title":"Health Sci Rep"},{"issue":"4","key":"pone.0251612.ref047","doi-asserted-by":"crossref","first-page":"e18435","DOI":"10.1371\/journal.pone.0018435","article-title":"Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana","volume":"6","author":"DA Gust","year":"2011","journal-title":"PLoS ONE"},{"issue":"4","key":"pone.0251612.ref048","first-page":"e89","article-title":"Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings","volume":"71","author":"H Huerga","year":"2016","journal-title":"JAIDS"},{"issue":"7","key":"pone.0251612.ref049","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/09540121.2017.1283390","article-title":"\"It\u2019s about my life\": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa","volume":"29","author":"KB Jacobson","year":"2017","journal-title":"AIDS Care"},{"issue":"4","key":"pone.0251612.ref050","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s10461-019-02675-6","article-title":"Promoting Tuberculosis Preventive Therapy for People Living with HIV in South Africa: Interventions Hindered by Complicated Clinical Guidelines and Imbalanced Patient-Provider Dynamics","volume":"24","author":"BA Jarrett","year":"2019","journal-title":"AIDS and Behavior"},{"issue":"10","key":"pone.0251612.ref051","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/QAD.0000000000000278","article-title":"Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped","volume":"28","author":"FA Khan","year":"2014","journal-title":"AIDS"},{"issue":"3","key":"pone.0251612.ref052","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5588\/ijtld.18.0378","article-title":"Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia","volume":"23","author":"J Lai","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"issue":"SUPPL. 5","key":"pone.0251612.ref053","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/01.aids.0000391021.18284.12","article-title":"Barriers to implementation of isoniazid preventive therapy in HIV clinics: A qualitative study","volume":"24","author":"R Lester","year":"2010","journal-title":"AIDS"},{"issue":"4","key":"pone.0251612.ref054","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5588\/ijtld.16.0836","article-title":"Predictors of isoniazid preventive therapy completion among adults newly diagnosed with HIV in rural Malawi","volume":"22","author":"KM Little","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0251612.ref055","doi-asserted-by":"crossref","DOI":"10.1186\/s13012-017-0574-z","article-title":"HIV policy implementation in two health and demographic surveillance sites in Uganda: Findings from a national policy review, health facility surveys and key informant interviews","volume":"12","author":"E McRobie","year":"2017","journal-title":"Implementation Science"},{"issue":"2","key":"pone.0251612.ref056","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5588\/pha.20.0003","article-title":"Sustaining tuberculosis preventive therapy scale-up through direct supportive supervision","volume":"10","author":"SC Meribe","year":"2020","journal-title":"Public Health Action"},{"issue":"1","key":"pone.0251612.ref057","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/1471-2458-11-916","article-title":"Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia","volume":"11","author":"M Mindachew","year":"2011","journal-title":"BMC public health"},{"issue":"1","key":"pone.0251612.ref058","doi-asserted-by":"crossref","DOI":"10.4102\/sajid.v34i1.10","article-title":"Tracking the rate of initiation and retention on isoniazid preventive therapy in a high human immunodeficiency virus and tuberculosis burden setting of Lesotho","volume":"34","author":"E Mugomeri","year":"2019","journal-title":"Southern African Journal of Infectious Diseases"},{"issue":"9","key":"pone.0251612.ref059","first-page":"1037","article-title":"Completion of isoniazid preventive therapy among HIV-infected patients in Tanzania","volume":"12","author":"P Munseri","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"pone.0251612.ref060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00002030-199701000-00016","article-title":"Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand","volume":"11","author":"J Ngamvithayapong","year":"1997","journal-title":"AIDS"},{"issue":"1","key":"pone.0251612.ref061","doi-asserted-by":"crossref","first-page":"1704540","DOI":"10.1080\/16549716.2019.1704540","article-title":"To start or to complete?\u2014Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India","volume":"13","author":"MM Reddy","year":"2020","journal-title":"Glob Health Action"},{"issue":"3","key":"pone.0251612.ref062","first-page":"263","article-title":"Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?","volume":"9","author":"KA Rowe","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"pone.0251612.ref063","article-title":"Provision of Isoniazid Preventive Therapy: The Experiences of People Living with HIV","volume":"21","author":"K Selehelo","year":"2019","journal-title":"African Journal of Nursing and Midwifery"},{"issue":"1","key":"pone.0251612.ref064","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-6-97","article-title":"Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa","volume":"6","author":"TA Szakacs","year":"2006","journal-title":"BMC infectious diseases"},{"issue":"1","key":"pone.0251612.ref065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09540121.2019.1619661","article-title":"Predictors of isoniazid preventive therapy completion among HIV-infected patients receiving differentiated and non-differentiated HIV care in rural Uganda","volume":"32","author":"KH Tram","year":"2019","journal-title":"AIDS Care"},{"issue":"2","key":"pone.0251612.ref066","doi-asserted-by":"crossref","first-page":"e0212035","DOI":"10.1371\/journal.pone.0212035","article-title":"Health system barriers to implementation of TB preventive strategies in South African primary care facilities","volume":"14","author":"E Van Ginderdeuren","year":"2019","journal-title":"PLoS ONE"},{"issue":"12","key":"pone.0251612.ref067","doi-asserted-by":"crossref","first-page":"e024286","DOI":"10.1136\/bmjopen-2018-024286","article-title":"Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: a qualitative study","volume":"8","author":"EOA Wambiya","year":"2018","journal-title":"BMJ Open"},{"key":"pone.0251612.ref068","unstructured":"The World Bank. World Bank country and lending groups 2021. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups."},{"key":"pone.0251612.ref069","unstructured":"Kates J, Wexler A, Lief E. Donor government funding for HIV in low-and middle-income countries in 2019 2020. https:\/\/files.kff.org\/attachment\/Donor-Government-Funding-for-HIV-in-Low-and-Middle-Income-Countries-in-2019.pdf."},{"key":"pone.0251612.ref070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijid.2020.09.011","article-title":"Ending the epidemic of HIV\/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?","volume":"100","author":"Y Assefa","year":"2020","journal-title":"International Journal of Infectious Diseases"},{"key":"pone.0251612.ref071","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2471\/BLT.09.066522","article-title":"Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV","volume":"88","author":"M Vitoria","year":"2010","journal-title":"Bulletin of the World Health Organization"},{"issue":"1670","key":"pone.0251612.ref072","doi-asserted-by":"crossref","first-page":"20140306","DOI":"10.1098\/rstb.2014.0306","article-title":"How could preventive therapy affect the prevalence of drug resistance? Causes and consequences","volume":"370","author":"A Kunkel","year":"2015","journal-title":"Philosophical Transactions of the Royal Society B: Biological Sciences"},{"key":"pone.0251612.ref073","first-page":"1","article-title":"Provider perspectives on the role of the patient as an active participant in HIV care","author":"C Kafu","year":"2020","journal-title":"Global public health"},{"key":"pone.0251612.ref074","unstructured":"Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 31th Edition: CLSI; 2020 [cited 35]. 1\u2013332]. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100-preorder\/."},{"key":"pone.0251612.ref075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","article-title":"Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing","volume":"20","author":"SC Ersoy","year":"2017","journal-title":"EBioMedicine"},{"issue":"2","key":"pone.0251612.ref076","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1258\/004947506776593314","article-title":"Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries","volume":"36","author":"R Zachariah","year":"2006","journal-title":"Tropical doctor"},{"issue":"1","key":"pone.0251612.ref077","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/her\/cyl039","article-title":"Written medicines information for South African HIV\/AIDS patients: does it enhance understanding of co-trimoxazole therapy?","volume":"22","author":"L Mansoor","year":"2006","journal-title":"Health Education Research"},{"issue":"5","key":"pone.0251612.ref078","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/fampra\/15.5.471","article-title":"A PIL for every ill? Patient information leaflets (PILs): a review of past, present and future use","volume":"15","author":"T Kenny","year":"1998","journal-title":"Family Practice"},{"key":"pone.0251612.ref079","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.socscimed.2018.10.030","article-title":"How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations","volume":"220","author":"K Hauck","year":"2019","journal-title":"Social science & medicine"},{"issue":"sup1","key":"pone.0251612.ref080","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/21665095.2018.1511378","article-title":"EU Donors and health system strengthening: the love-hate relationship with the Global Fund","volume":"5","author":"L Steurs","year":"2018","journal-title":"Development Studies Research"},{"issue":"7","key":"pone.0251612.ref081","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/heapol\/czw009","article-title":"Did PEPFAR investments result in health system strengthening? A retrospective longitudinal study measuring non-HIV health service utilization at the district level","volume":"31","author":"SA Luboga","year":"2016","journal-title":"Health Policy Plan"},{"key":"pone.0251612.ref082","unstructured":"USAID. USAID\u2019s vision for health systems strengthening 2030: Author Washington, DC; 2021. https:\/\/www.usaid.gov\/sites\/default\/files\/documents\/USAID_OHS_VISION_Report_FINAL_single_5082.pdf."},{"key":"pone.0251612.ref083","unstructured":"World Health Organization. Healthy systems for universal health coverage: a joint vision for healthy lives 2018. https:\/\/www.uhc2030.org\/fileadmin\/uploads\/uhc2030\/Documents\/About_UHC2030\/mgt_arrangemts___docs\/UHC2030_Official_documents\/UHC2030_vision_paper_WEB2.pdf."},{"key":"pone.0251612.ref084","unstructured":"Global Fund. The Global Fund Strategy 2017\u20132022: investing to end epidemics: Reliefweb; 2017. https:\/\/www.theglobalfund.org\/media\/2531\/core_globalfundstrategy2017-2022_strategy_en.pdf."},{"key":"pone.0251612.ref085","unstructured":"USAID. ADS Chapter 220: Use and Strengthening of Reliable Partner Government Systems for Implementation of Direct Assistance 2014. https:\/\/2012-2017.usaid.gov\/sites\/default\/files\/documents\/1868\/220.pdf."},{"issue":"3","key":"pone.0251612.ref086","first-page":"77","article-title":"Health system strengthening: a qualitative evaluation of implementation experience and lessons learned across five African countries","volume":"17","author":"FC Rwabukwisi","year":"2017","journal-title":"BMC health services research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251612","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T13:27:29Z","timestamp":1646141249000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0251612"}},"subtitle":[],"editor":[{"given":"Orvalho","family":"Augusto","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0251612","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.04.30.21256370","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}